CD8A and neoplasm: Mattarollo et al. have shown the effect of doxorubicin treatment is dependent on CD8 + T cells and gamma interferon, and doxorubicin treatment enhances tumor antigen-specific proliferation of CD8 + T cells in tumor-draining lymph nodes and promotes tumor infiltration of activated IFN-γ-producing cells [16].